TY - JOUR
T1 - Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G
AU - King, Madeleine T.
AU - Stockler, Martin R.
AU - Cella, David F.
AU - Osoba, David
AU - Eton, David T.
AU - Thompson, Joanna
AU - Eisenstein, Amy R.
N1 - Funding Information:
This research was funded by an educational grant from AstraZeneca. We are indebted to Liz Chinchen, CHERE's librarian, for developing and testing our electronic search strategy, for identifying and searching all relevant online bibliographic databases, for helping identify potential source papers, and for collecting them. We would also like to thank Julia Brown, Peter Fayers, Kim Hawkins, and Galina Velikova for helpful comments about the results.
PY - 2010/3
Y1 - 2010/3
N2 - Objective: To compare Cohen's guidelines for small (0.2), medium (0.5), and large (0.8) effect sizes with empirical estimates for a cancer-specific health-related quality-of-life questionnaire (HRQOL), the Functional Assessment of Cancer Therapy - General (FACT-G). Methods: Seventy-one papers satisfied inclusion criteria for meta-analysis. Blinded to the HRQOL results, three "experts" (with expertise in interpreting the FACT-G questionnaire and managing cancer patients), predicted the relative magnitude of HRQOL mean differences. Size classes (small, medium, large) were defined in terms of relevance to clinical decision making. The experts worked independently and based their predictions on patient characteristics and clinical circumstances. Their judgments were linked with FACT-G results and inverse-variance-weighted mean effect sizes calculated for each size class. Results: At least two experts were perfectly concordant and up to one was discordant by at most one size category for 833 of the mean differences; for these, weighted kappas were generally in the "substantial" range (0.60-0.79). Of these mean differences, 617 were cross-sectional; small, medium, and large mean effect sizes were physical well-being 0.42, 0.87, 1.6; functional well-being 0.37, 0.71, 1.6; emotional well-being 0.32, 0.40, no large differences; and social well-being 0.14, 0.23, no large differences. Two hundred and sixteen longitudinal mean differences yielded small and medium effect sizes: physical well-being 0.26, 0.34; functional well-being 0.14, 0.28; emotional well-being 0.27, 0.23; and social well-being 0.08, 0.01. There was virtually no evidence for large longitudinal effects. Conclusion: These results provide specific, evidence-based alternatives to Cohen's generic guidelines, for use in sample-size calculations for the FACT-G and interpretation of the clinical significance of effects measured with FACT-G.
AB - Objective: To compare Cohen's guidelines for small (0.2), medium (0.5), and large (0.8) effect sizes with empirical estimates for a cancer-specific health-related quality-of-life questionnaire (HRQOL), the Functional Assessment of Cancer Therapy - General (FACT-G). Methods: Seventy-one papers satisfied inclusion criteria for meta-analysis. Blinded to the HRQOL results, three "experts" (with expertise in interpreting the FACT-G questionnaire and managing cancer patients), predicted the relative magnitude of HRQOL mean differences. Size classes (small, medium, large) were defined in terms of relevance to clinical decision making. The experts worked independently and based their predictions on patient characteristics and clinical circumstances. Their judgments were linked with FACT-G results and inverse-variance-weighted mean effect sizes calculated for each size class. Results: At least two experts were perfectly concordant and up to one was discordant by at most one size category for 833 of the mean differences; for these, weighted kappas were generally in the "substantial" range (0.60-0.79). Of these mean differences, 617 were cross-sectional; small, medium, and large mean effect sizes were physical well-being 0.42, 0.87, 1.6; functional well-being 0.37, 0.71, 1.6; emotional well-being 0.32, 0.40, no large differences; and social well-being 0.14, 0.23, no large differences. Two hundred and sixteen longitudinal mean differences yielded small and medium effect sizes: physical well-being 0.26, 0.34; functional well-being 0.14, 0.28; emotional well-being 0.27, 0.23; and social well-being 0.08, 0.01. There was virtually no evidence for large longitudinal effects. Conclusion: These results provide specific, evidence-based alternatives to Cohen's generic guidelines, for use in sample-size calculations for the FACT-G and interpretation of the clinical significance of effects measured with FACT-G.
KW - Cancer
KW - FACT-G
KW - Health-related quality of life
KW - Interpretation guidelines
KW - MCID
KW - MID
KW - Meta-analysis
KW - Minimum clinically important difference
KW - Minimum important difference
KW - Patient-reported outcomes
UR - http://www.scopus.com/inward/record.url?scp=75749129441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75749129441&partnerID=8YFLogxK
U2 - 10.1016/j.jclinepi.2009.05.001
DO - 10.1016/j.jclinepi.2009.05.001
M3 - Article
C2 - 19716264
AN - SCOPUS:75749129441
SN - 0895-4356
VL - 63
SP - 270
EP - 281
JO - American journal of syphilis, gonorrhea, and venereal diseases
JF - American journal of syphilis, gonorrhea, and venereal diseases
IS - 3
ER -